Answers are grounded in this paper and cite their sources.
Background Accurate quantification of free fatty acids (FFAs) in complex biological matrices in human serum is analytically challenging due to variations in carbon chain length, polarity, and volatility.Method In this study, we describe a targeted GC-MS (gas chromatography mass spectrometry) method for simultaneous profiling of 34 serum FFAs (C4-C24) spanning short-, medium-, and long-chain saturated and unsaturated fatty acids and evaluate its analytical performance and clinical applicability in ALL (Acute Lymphoblastic Leukemia). A one-step Folch extraction with Meth Prep II methylation was optimized for preparation of FAMEs (fatty acid methyl esters) and compounds were detected in selected ion monitoring (SIM) mode.Results Analytical validation showed excellent linearity across the calibration range (3.7–60 µg/mL) with coefficients of determination (R2) ranging from 0.9917 to 0.9994 across the analytes. Sub µg/mL LOD values ranged from 0.0001–0.137 µg/mL, LOQ values from 0.0003–0.457 µg/mL, and lowest calibration values from 3.3–13.85 µg/mL, corresponding to lowest calibration levels. Inter-day RSD% (precision) were ±10% across analytes, while RE% (accuracy) were within ±20%. Clinical applicability was evaluated serum samples from newly diagnosed ALL patients at baseline (N = 142) and post-induction chemotherapy (N = 123). Multivariate clustering confirmed clear separation between clinical groups.Conclusion Overall, this fit-for-purpose GC-MS profiling supports clinical metabolomics investigations of lipid dysregulation in ALL.
No takes yet. Share an insight, caveat, or question.
Thomas et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: